This Article Full Text Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Reprints and Permissions Copyright Information Books from ASM Press MicrobeWorld Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Briones, M. L. Articles by Marín, J. Search for Related Content PubMed PubMed Citation Articles by Briones, M. L. Articles by Marín, J.

 Previous Article  |  Next Article 

Clinical and Vaccine Immunology, October 2006, p. 1092-1097, Vol. 13, No. 10
1071-412X/06/$08.00+0     doi:10.1128/CVI.00090-06
Copyright © 2006, American Society for Microbiology. All Rights Reserved.

Assessment of Analysis of Urinary Pneumococcal Antigen by Immunochromatography for Etiologic Diagnosis of Community-Acquired Pneumonia in Adults

Pneumology Department,¹ Respiratory Intensive Care Unit,² Microbiology Department, Hospital Clínico Universitario, Universitat de València, Valencia, Spain³

Received 2 March 2006/ Returned for modification 23 May 2006/ Accepted 26 July 2006

The limitations of conventional microbiologic methods (CMM) for etiologic diagnosis of community pneumococcal pneumonia have made faster diagnostic techniques necessary. Our aim was to evaluate the usefulness of the immunochromatography (ICT) technique for detecting urinary Streptococcus pneumoniae antigen in the etiologic diagnosis of community-acquired pneumonias (CAP). This was a prospective study on in-patients with CAP in a tertiary hospital conducted from October 2000 to March 2004. Apart from using CMM to reach an etiologic diagnosis, we determined pneumococcal antigen in concentrated urine by ICT. We also determined the urinary pneumococcal antigen (UPA) content in patients from two control groups to calculate the specificity of the technique. One group was comprised of in-patients diagnosed with chronic obstructive pulmonary disease (COPD) or asthma, with respiratory infection, and without pneumonia; the other group included fractures. We studied 959 pneumonia patients and determined UPA content in 911 (95%) of them. We diagnosed the etiology of 253 cases (28%) using CMM; S. pneumoniae was the most common etiologic agent (57 cases). ICT analysis was positive for 279 patients (31%). Using this technique, the percentage of diagnoses of pneumococcal pneumonias increased by 26%, while the overall etiologic diagnosis increased from 28 to 49%. The technique sensitivity was 81%; the specificity oscillated between 80% in CAP with nonpneumococcal etiology and 99% for patients with fractures without infections. Determination of UPA is a rapid, simple analysis with good sensitivity and specificity, which increased the percentage of etiologic diagnoses. Positive UPA may persist in COPD patients with probable pneumococcal colonization or recent pneumococcal infections.

This article has been cited by other articles:

• del Mar Garcia-Suarez, M., Cima-Cabal, M. D., Villaverde, R., Espinosa, E., Falguera, M., de Los Toyos, J. R., Vazquez, F., Mendez, F. J. (2007). Performance of a Pneumolysin Enzyme-Linked Immunosorbent Assay for Diagnosis of Pneumococcal Infections. J. Clin. Microbiol. 45: 3549-3554 [Abstract] [Full Text]